Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
10:53
Radu Miruță, declared incompatible by ANI
10:48
NATO and its allies conducted a major aerial surveillance mission on Thursday over the Black Sea and along the eastern flank
10:45
Emmanuel Macron meets with former U.S. Vice President Kamala Harris in Paris amid tensions with Donald Trump
10:41
EXCLUSIVE | Romania, as viewed by the Russian press / The scenario of unification with the Republic of Moldova, described as a “capitulation” of Chișinău
10:37
Hippopotamus Fiona died at the Cincinnati Zoo after swallowing a hat that accidentally ended up in her enclosure
See more news